Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016

Watchlist Manager
Shanghai MicroPort Endovascular MedTech Group Co Ltd Logo
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Watchlist
Price: 85.63 CNY 0.26% Market Closed
Market Cap: 10.6B CNY
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+58%
Revenue
Forecast
+22%
Operating Income
Forecast
N/A
Net Income
Forecast
+20%

Wall Street
Price Targets

Price Targets Summary
Shanghai MicroPort Endovascular MedTech Group Co Ltd

Wall Street analysts forecast Shanghai MicroPort Endovascular MedTech Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort Endovascular MedTech Group Co Ltd is 135.01 CNY with a low forecast of 121.2 CNY and a high forecast of 147 CNY.

Lowest Forecast
Wall Street Target
121.2 CNY
42% Upside
Average Forecast
Wall Street Target
135.01 CNY
58% Upside
Highest Forecast
Wall Street Target
147 CNY
72% Upside
Lowest
Price Target
121.2 CNY
42% Upside
Average
Price Target
135.01 CNY
58% Upside
Highest
Price Target
147 CNY
72% Upside
Shanghai MicroPort Endovascular MedTech Group Co Ltd Competitors:
Price Targets
V
VIMIAN
Vimian Group AB
40% Upside
T
TOPGLOV
Top Glove Corporation Bhd
14% Upside
OSUR
OraSure Technologies Inc
71% Upside
PNV
Polynovo Ltd
87% Upside
V
VIMIAN
Vimian Group AB
40% Upside
T
TOPGLOV
Top Glove Corporation Bhd
14% Upside
OSUR
OraSure Technologies Inc
71% Upside
PNV
Polynovo Ltd
87% Upside
XVIVO
Xvivo Perfusion AB
54% Upside
K
9997
Kangji Medical Holdings Ltd
24% Upside
137310
SD Biosensor Inc
21% Upside
UFPT
UFP Technologies Inc
88% Upside

Revenue
Forecast

Revenue Estimate
Shanghai MicroPort Endovascular MedTech Group Co Ltd

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's revenue is 33%. The projected CAGR for the next 3 years is 22%.

33%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shanghai MicroPort Endovascular MedTech Group Co Ltd

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's operating income is 35%. The projected CAGR for the next 2 years is 23%.

35%
Past Growth
23%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shanghai MicroPort Endovascular MedTech Group Co Ltd

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's net income is 34%. The projected CAGR for the next 3 years is 20%.

34%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's stock price target?
Price Target
135.01 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort Endovascular MedTech Group Co Ltd is 135.01 CNY with a low forecast of 121.2 CNY and a high forecast of 147 CNY.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Revenue forecast?
Projected CAGR
22%

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's revenue is 33%. The projected CAGR for the next 3 years is 22%.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Operating Income forecast?
Projected CAGR
23%

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's operating income is 35%. The projected CAGR for the next 2 years is 23%.

What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Net Income forecast?
Projected CAGR
20%

For the last 7 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's net income is 34%. The projected CAGR for the next 3 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.